| VICINIUM |
| A Phase I/II Study of Vicinium™ Given by Intravesical Administration in Patients with Superficial Transitional Cell Carcinoma of the Bladder: Phase I Final Results |
View Abstract |
| Treatment with Intravesical Vicinium™ Results in Durable Responses in Patients with Carcinoma in situ (CIS) Previously Treated With Bacille Calmette-Guérin (BCG) |
View Abstract |
| Frequency and Level of Expression of EpCAM in Non Muscle-Invasive Transitional Cell Carcinoma of the Bladder |
View Abstract |
| Level of Expression of EpCAM and Response to Vicinium™ in Non Muscle-Invasive Transitional Cell Carcinoma of the Bladder |
View Abstract |
| VB6-845 |
| A Phase I Study of VB6-845, an Anti-EpCAM Fusion Protein Targeting Advanced Solid Tumours of Epithelial Origin: Preliminary Results |
View Abstract |
